Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Authors
Gaffney, DairenaForster, Lorne
Caslake, Muriel J
Bedford, Dorothy
Stewart, J Philip
Stewart, Grace
Wieringa, Gilbert E
Dominiczak, Marek
Miller, J Paul
Packard, Chris J
Affiliation
Department of Pathological Biochemistry, Glasgow Royal Infirmary, North Glasgow Hospitals University NHS trust, 4th floor, Queen Elizabeth Building, Alexandra Parade, Glasgow G31 2ER, Scotland, UK. dairena.gaffney@clinmed.gla.ac.ukIssue Date
2002-05
Metadata
Show full item recordAbstract
Both defective LDL receptors (familial hypercholesterolaemia, FH) and mutations in apolipoprotein B (apoB) on LDL (familial defective apoB, FDB) give rise to a phenotype of elevated LDL cholesterol. We sought to compare the metabolic basis of the two conditions by examining apoB turnover in FDB and FH subjects. A group comprising three heterozygous and one homozygous FDB subjects were compared with five FH heterozygotes and 17 control subjects using a deuterated leucine tracer. Kinetic parameters were derived by multicompartmental modelling. FH heterozygotes had a reduced delipidation rate for VLDL, which led to a moderate increase in plasma triglyceride. Compared with controls and FH, the FDB subjects converted 44% less IDL to LDL. The LDL FCR was reduced to a similar extent in FDB and FH. In all subjects LDL plasma levels appeared to be regulated by the LDL FCR and the rate of production of small VLDL. We conclude that disturbances in IDL metabolism provide the basis for understanding why FDB is less severe than FH. Our findings suggest that an apoB-LDL receptor interaction is important in the IDL to LDL conversion.Citation
Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia. 2002, 162 (1):33-43 AtherosclerosisJournal
AtherosclerosisPubMed ID
11947895Type
ArticleLanguage
enISSN
0021-9150Collections
Related articles
- Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
- Authors: Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Bergeron J, Gagné C, Couture P
- Issue date: 2004 May
- Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
- Authors: Miserez AR, Keller U
- Issue date: 1995 Oct
- Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
- Authors: Fisher WR, Zech LA, Kilgore LL, Stacpoole PW
- Issue date: 1991 Nov
- ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
- Authors: Fisher WR, Zech LA, Stacpoole PW
- Issue date: 1994 Apr
- Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
- Authors: Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ
- Issue date: 2004 Aug